Connection

Graham Warren to Humans

Back to Details
This is a "connection" page, showing publications Graham Warren has written about Humans.
Graham Warren
Connection Strength
1.219
Humans
  1. Challenges and Adaptations for Providing Smoking Cessation for Patients with Cancer across Canada during the COVID-19 Pandemic. Curr Oncol. 2022 03 24; 29(4):2263-2271.
    View in: PubMed
    Score: 0.032
  2. New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019. J Thorac Oncol. 2021 11; 16(11):1946-1951.
    View in: PubMed
    Score: 0.030
  3. Critical Determinants of Cancer Treatment Outcomes: Smoking Must Be Addressed at the Highest Levels in Cancer Care. J Thorac Oncol. 2021 06; 16(6):891-893.
    View in: PubMed
    Score: 0.030
  4. Cost evaluation of tobacco control interventions in clinical settings: A systematic review. Prev Med. 2021 05; 146:106469.
    View in: PubMed
    Score: 0.030
  5. Smoking-Cessation Methods and Outcomes Among Cancer Survivors. Am J Prev Med. 2020 10; 59(4):615-617.
    View in: PubMed
    Score: 0.028
  6. A Call for Rapid Submission of Data for Aggregate Review: Can Daily Radiotherapy Imaging Be Used as a Potential Screen for Coronavirus Disease 2019? J Thorac Oncol. 2020 06; 15(6):876-877.
    View in: PubMed
    Score: 0.028
  7. Smoking Cessation After a Cancer Diagnosis Is Associated With Improved Survival. J Thorac Oncol. 2020 05; 15(5):705-708.
    View in: PubMed
    Score: 0.028
  8. Using a Quitline to Deliver Opt-Out Smoking Cessation for Cancer Patients. JCO Oncol Pract. 2020 06; 16(6):e549-e556.
    View in: PubMed
    Score: 0.028
  9. Tobacco and E-cigarette use among cancer survivors in the United States. PLoS One. 2019; 14(12):e0226110.
    View in: PubMed
    Score: 0.027
  10. Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States. Nicotine Tob Res. 2019 10 26; 21(11):1453-1461.
    View in: PubMed
    Score: 0.027
  11. Smoking Cessation and Low-Dose Computed Tomography Screening: A Necessary Pair. J Thorac Oncol. 2019 09; 14(9):1495-1497.
    View in: PubMed
    Score: 0.027
  12. Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With Cancer. JAMA Netw Open. 2019 04 05; 2(4):e191703.
    View in: PubMed
    Score: 0.026
  13. American Society of Clinical Oncology Policy Brief: FDA's Regulation of Electronic Nicotine Delivery Systems and Tobacco Products. J Oncol Pract. 2017 01; 13(1):58-60.
    View in: PubMed
    Score: 0.022
  14. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clin Cancer Res. 2016 Apr 15; 22(8):1907-13.
    View in: PubMed
    Score: 0.021
  15. Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco. Am Soc Clin Oncol Educ Book. 2016; 35:223-9.
    View in: PubMed
    Score: 0.021
  16. Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients. J Thorac Oncol. 2015 Nov; 10(11):1532-7.
    View in: PubMed
    Score: 0.021
  17. Perspective on the National Comprehensive Cancer Network's Clinical Practice Guidelines for Smoking Cessation. J Oncol Pract. 2016 Jan; 12(1):55-8.
    View in: PubMed
    Score: 0.020
  18. Business as usual is not acceptable. Cancer. 2015 Sep 01; 121(17):2864-5.
    View in: PubMed
    Score: 0.020
  19. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. 2015 Mar 10; 33(8):952-63.
    View in: PubMed
    Score: 0.019
  20. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res. 2015 Feb 01; 21(3):514-25.
    View in: PubMed
    Score: 0.019
  21. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 2014 Nov; 15(12):e568-80.
    View in: PubMed
    Score: 0.019
  22. The biologic effects of cigarette smoke on cancer cells. Cancer. 2014 Dec 01; 120(23):3617-26.
    View in: PubMed
    Score: 0.019
  23. Cigarette smoking and systemic therapy for lung cancer: considering the evidence to improve cancer care. J Thorac Oncol. 2014 Jul; 9(7):914-916.
    View in: PubMed
    Score: 0.019
  24. How can patients who are not referred for treatment receive the best treatment available? Cancer. 2014 Jun 01; 120(11):1750-1.
    View in: PubMed
    Score: 0.019
  25. The 2014 Surgeon General's report: "The health consequences of smoking--50 years of progress": a paradigm shift in cancer care. Cancer. 2014 Jul 01; 120(13):1914-6.
    View in: PubMed
    Score: 0.018
  26. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):3-9.
    View in: PubMed
    Score: 0.018
  27. Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014 Feb 15; 120(4):562-9.
    View in: PubMed
    Score: 0.018
  28. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013 Sep; 9(5):258-62.
    View in: PubMed
    Score: 0.018
  29. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013 May; 8(5):543-8.
    View in: PubMed
    Score: 0.017
  30. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. 2013 Jun; 24(6):1223-30.
    View in: PubMed
    Score: 0.017
  31. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book. 2013; 359-64.
    View in: PubMed
    Score: 0.017
  32. Author's reply to: Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013 Feb 15; 132(4):992.
    View in: PubMed
    Score: 0.016
  33. Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol. 2012 Aug 10; 30(23):2869-75.
    View in: PubMed
    Score: 0.016
  34. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013 Jan 15; 132(2):401-10.
    View in: PubMed
    Score: 0.016
  35. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012 Dec 01; 131(11):2519-27.
    View in: PubMed
    Score: 0.016
  36. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. 2012 Apr; 103(1):45-8.
    View in: PubMed
    Score: 0.016
  37. In situ cleavage of the acidic domain from the p115 tether inhibits exocytic transport. Traffic. 2008 Sep; 9(9):1522-9.
    View in: PubMed
    Score: 0.012
  38. Selectively enhanced radiation sensitivity in prostate cancer cells associated with proteasome inhibition. Oncol Rep. 2006 May; 15(5):1287-91.
    View in: PubMed
    Score: 0.011
  39. Golgin tethers define subpopulations of COPI vesicles. Science. 2005 Feb 18; 307(5712):1095-8.
    View in: PubMed
    Score: 0.010
  40. Mapping the functional domains of the Golgi stacking factor GRASP65. J Biol Chem. 2005 Feb 11; 280(6):4921-8.
    View in: PubMed
    Score: 0.010
  41. A direct role for GRASP65 as a mitotically regulated Golgi stacking factor. EMBO J. 2003 Jul 01; 22(13):3279-90.
    View in: PubMed
    Score: 0.009
  42. Biochemical sub-fractionation of the mammalian Golgi apparatus. Traffic. 2003 May; 4(5):344-52.
    View in: PubMed
    Score: 0.009
  43. Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):12-21.
    View in: PubMed
    Score: 0.008
  44. The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers. Nicotine Tob Res. 2023 01 05; 25(2):345-349.
    View in: PubMed
    Score: 0.008
  45. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer. JAMA Netw Open. 2022 12 01; 5(12):e2245818.
    View in: PubMed
    Score: 0.008
  46. Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res. 2022 Nov 14; 28(22):4861-4870.
    View in: PubMed
    Score: 0.008
  47. The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems. PLoS One. 2022; 17(9):e0274571.
    View in: PubMed
    Score: 0.008
  48. Golgi biogenesis in Toxoplasma gondii. Nature. 2002 Aug 01; 418(6897):548-52.
    View in: PubMed
    Score: 0.008
  49. LKB1 phosphorylation and deactivation in lung cancer by NNAL, a metabolite of tobacco-specific carcinogen, in an isomer-dependent manner. Oncogene. 2022 08; 41(33):4042-4054.
    View in: PubMed
    Score: 0.008
  50. Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology. Cancer Epidemiol. 2022 08; 79:102210.
    View in: PubMed
    Score: 0.008
  51. Ignoring the Obvious: Smoking Cessation Improves Survival. J Thorac Oncol. 2022 05; 17(5):596-598.
    View in: PubMed
    Score: 0.008
  52. Associations between cancer diagnosis and patients' responses to an inpatient tobacco treatment intervention. Cancer Med. 2021 08; 10(15):5329-5337.
    View in: PubMed
    Score: 0.008
  53. Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial. BMJ Open. 2021 06 29; 11(6):e051226.
    View in: PubMed
    Score: 0.008
  54. Concordance Between Electronic Health Record and Tumor Registry Documentation of Smoking Status Among Patients With Cancer. JCO Clin Cancer Inform. 2021 05; 5:518-526.
    View in: PubMed
    Score: 0.008
  55. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.007
  56. Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres. Implement Sci. 2021 03 04; 16(1):23.
    View in: PubMed
    Score: 0.007
  57. Negative affect and the utilization of tobacco treatment among adult smokers with cancer. Psychooncology. 2021 01; 30(1):93-102.
    View in: PubMed
    Score: 0.007
  58. European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus?palliative cancer treatment. Eur J Cancer. 2020 10; 138:99-108.
    View in: PubMed
    Score: 0.007
  59. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.007
  60. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers. Front Public Health. 2020; 8:221.
    View in: PubMed
    Score: 0.007
  61. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020 07; 15(7):1119-1136.
    View in: PubMed
    Score: 0.007
  62. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.007
  63. An Implementation Trial to Improve Tobacco Treatment for Cancer Patients: Patient Preferences, Treatment Acceptability and Effectiveness. Int J Environ Res Public Health. 2020 03 28; 17(7).
    View in: PubMed
    Score: 0.007
  64. Modeling rectal cancer to advance neoadjuvant precision therapy. Int J Cancer. 2020 09 01; 147(5):1405-1418.
    View in: PubMed
    Score: 0.007
  65. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.006
  66. Indeed, Nuance Matters. J Thorac Oncol. 2019 01; 14(1):e16-e17.
    View in: PubMed
    Score: 0.006
  67. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.006
  68. Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 1-Year Postdischarge Health Care Costs. Med Care. 2018 10; 56(10):883-889.
    View in: PubMed
    Score: 0.006
  69. Evaluation of a Dedicated Tobacco Cessation Support Service for Thoracic Cancer Center Patients. J Public Health Manag Pract. 2018 Sep/Oct; 24(5):E12-E19.
    View in: PubMed
    Score: 0.006
  70. "Teachable Moment" Interventions in Lung Cancer: Why Action Matters. J Thorac Oncol. 2018 05; 13(5):603-605.
    View in: PubMed
    Score: 0.006
  71. Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 30-, 90-, and 180-Day Hospital Readmission Rates. Med Care. 2018 04; 56(4):358-363.
    View in: PubMed
    Score: 0.006
  72. Cannabis Use, Lung Cancer, and Related Issues. J Thorac Oncol. 2018 04; 13(4):480-487.
    View in: PubMed
    Score: 0.006
  73. Feasibility of Implementing a Hospital-Based "Opt-Out" Tobacco-Cessation Service. Nicotine Tob Res. 2017 Aug 01; 19(8):937-943.
    View in: PubMed
    Score: 0.006
  74. A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent. Cancer Chemother Pharmacol. 2017 Sep; 80(3):497-505.
    View in: PubMed
    Score: 0.006
  75. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2017 Sep 01; 23(17):5055-5065.
    View in: PubMed
    Score: 0.006
  76. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017 May; 6(5):944-952.
    View in: PubMed
    Score: 0.006
  77. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011. Laryngoscope. 2017 05; 127(5):1087-1092.
    View in: PubMed
    Score: 0.006
  78. Tobacco assessment in completed lung cancer treatment trials. Cancer. 2016 11 15; 122(21):3260-3262.
    View in: PubMed
    Score: 0.005
  79. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
    View in: PubMed
    Score: 0.005
  80. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. Laryngoscope. 2016 12; 126(12):2733-2738.
    View in: PubMed
    Score: 0.005
  81. Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer. 2016 06 01; 122(11):1728-34.
    View in: PubMed
    Score: 0.005
  82. Scientific Advances in Lung Cancer 2015. J Thorac Oncol. 2016 05; 11(5):613-638.
    View in: PubMed
    Score: 0.005
  83. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.005
  84. Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res. 2016 08; 18(8):1684-96.
    View in: PubMed
    Score: 0.005
  85. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer. Gynecol Oncol. 2016 Jan; 140(1):124-30.
    View in: PubMed
    Score: 0.005
  86. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.005
  87. Tobacco Cessation May Improve Lung Cancer Patient Survival. J Thorac Oncol. 2015 Jul; 10(7):1014-9.
    View in: PubMed
    Score: 0.005
  88. E-cigarettes and cancer patients. J Thorac Oncol. 2014 Apr; 9(4):438-41.
    View in: PubMed
    Score: 0.005
  89. Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop. Oncologist. 2014 Jan; 19(1):21-31.
    View in: PubMed
    Score: 0.005
  90. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. 2014 May; 36(5):694-701.
    View in: PubMed
    Score: 0.004
  91. Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol. 2013 Dec; 20(13):4239-44.
    View in: PubMed
    Score: 0.004
  92. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer. 2013 Oct; 21(10):2825-33.
    View in: PubMed
    Score: 0.004
  93. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3156-61.
    View in: PubMed
    Score: 0.004
  94. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013 May 01; 11(5):531-46.
    View in: PubMed
    Score: 0.004
  95. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013 Apr 15; 19(8):1941-8.
    View in: PubMed
    Score: 0.004
  96. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Arch Intern Med. 2012 Jul 09; 172(13):1005-11.
    View in: PubMed
    Score: 0.004
  97. Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Head Neck. 2013 May; 35(5):684-8.
    View in: PubMed
    Score: 0.004
  98. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer. Med Dosim. 2012; 37(2):182-5.
    View in: PubMed
    Score: 0.004
  99. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ. 2011 Sep; 26(3):577-82.
    View in: PubMed
    Score: 0.004
  100. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw. 2011 Aug 01; 9(8):830-87.
    View in: PubMed
    Score: 0.004
  101. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther. 2011 Sep; 13(9):945-9.
    View in: PubMed
    Score: 0.004
  102. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011 Apr 25; 6:41.
    View in: PubMed
    Score: 0.004
  103. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. 2011 Nov; 33(11):1561-8.
    View in: PubMed
    Score: 0.004
  104. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Mol Cancer Ther. 2007 Sep; 6(9):2477-86.
    View in: PubMed
    Score: 0.003
  105. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Oncol Rep. 2006 Oct; 16(4):771-6.
    View in: PubMed
    Score: 0.003
  106. Ultrasound-guided fine-needle aspiration biopsy remains a valid approach in the evaluation of nonpalpable breast lesions. Diagn Cytopathol. 2004 May; 30(5):325-31.
    View in: PubMed
    Score: 0.002
  107. Transferrin receptor recycling in the absence of perinuclear recycling endosomes. J Cell Biol. 2002 Mar 04; 156(5):797-804.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.